NEKTAR THERAPEUTICS USD0.0001 (REV SPLIT) revenue breakdown overview

NEKTAR THERAPEUTICS USD0.0001 (REV SPLIT) revenue for the last year amounted to 98.43 M USD, the most of which — 98.43 M USD — came from its highest performing source at the moment, Novel Drug Candidates, the year earlier bringing 90.12 M USD. The greatest contribution to the revenue figure was made by Rest of World — last year it brought NEKTAR THERAPEUTICS USD0.0001 (REV SPLIT) 97.05 M USD, and the year before that — 78.64 M USD.